BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,524,169 | +56.0% | 704,383 | +54.9% | 9.85% | +47.9% |
| Q2 2023 | $49,066,597 | +13.2% | 454,615 | +30.6% | 6.66% | +53.6% |
| Q1 2023 | $43,346,000 | +10.1% | 347,965 | +32.8% | 4.34% | -10.0% |
| Q4 2022 | $39,368,306 | +8.1% | 262,071 | -3.0% | 4.82% | +16.3% |
| Q3 2022 | $36,425,288 | -18.8% | 270,057 | -10.2% | 4.14% | +6.2% |
| Q2 2022 | $44,838,000 | -34.6% | 300,721 | -25.2% | 3.90% | +31.8% |
| Q1 2022 | $68,606,000 | +365.3% | 402,239 | +603.3% | 2.96% | +229.6% |
| Q4 2021 | $14,744,000 | +2600.4% | 57,190 | +2759.5% | 0.90% | +2465.7% |
| Q3 2021 | $546,000 | -91.0% | 2,000 | -92.6% | 0.04% | -90.7% |
| Q2 2021 | $6,045,000 | -29.4% | 27,000 | -65.6% | 0.38% | -30.4% |
| Q1 2021 | $8,567,000 | +1006.8% | 78,460 | +725.9% | 0.54% | +721.2% |
| Q4 2020 | $774,000 | – | 9,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |